Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans.
about
Mechanism of the sex difference in endothelial dysfunction after strokeThe role of epoxyeicosatrienoic acids in the cardiovascular systemSoluble epoxide hydrolase: gene structure, expression and deletionEstrogen, aging and the cardiovascular systemGenetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humansEpoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor responseDysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosaGenetic variation in soluble epoxide hydrolase: association with outcome after aneurysmal subarachnoid hemorrhageSoluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertensionSoluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single AgentInhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signalingEpoxyeicosanoid signaling in CNS function and diseaseCytochrome P450 eicosanoids and cerebral vascular functionEpoxides and soluble epoxide hydrolase in cardiovascular physiologyHypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.Role of soluble epoxide hydrolase in age-related vascular cognitive decline.Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice.Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.Inhibition of the soluble epoxide hydrolase by tyrosine nitration.EDHF: an update.Synergistic Effect of the MTHFR C677T and EPHX2 G860A Polymorphism on the Increased Risk of Ischemic Stroke in Chinese Type 2 Diabetic Patients.Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases.Cytochrome P450 eicosanoids in cerebrovascular function and disease.Interactions Among CYP2C8, EPHX2, and CYP4A11 Variants and CYP Plasma Metabolite Levels in Ischemic Stroke.Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Cardiovascular Diseases: A Literature Review.Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.
P2860
Q27001603-CB2DDABF-20D1-421E-8FBD-689EC874DA77Q28256560-4AD22563-0D54-43E3-87BD-26E03215ABA6Q28291292-EE7770BF-A5DD-42E8-A085-9B994A6D8500Q28383144-5DB1A92B-5E8E-43D0-BF80-7A7C39ED4414Q28385730-49228D23-5AC3-4EC8-9D44-74DE2F40952EQ28386966-F2F29F93-1DCA-4AFE-9FCF-8E7D25A5F207Q28390115-4E6F53BB-2837-4201-8A07-D748E4C09F1CQ28390328-98DE3A8A-71CC-4DC9-BD8F-C1DDBEBDC1A1Q28390972-534528D8-92F4-409C-BB13-25E9F97525AEQ28391163-B22F0F70-BBD9-4EF8-BA2A-26FF970D74C0Q28393594-41A522B1-F666-4C0A-8C78-C1DF6C6FBB4AQ28394441-219A8C6C-C3DA-466F-A0FF-121C3F914800Q28396302-2B9C2A45-4900-408A-8C45-35B659761EB3Q28396313-4118B274-7208-4DFF-A27E-90CB8E1BF6A5Q33814824-1DC97D84-3BBB-482E-8903-A37DC582577CQ34622501-10C2C89D-ACB0-4BCB-B960-54327692ACC5Q34969971-68D03F90-8625-4B66-9984-7CE613006EA3Q37197332-BA39511C-C387-462A-B045-8EA82ADDEF27Q37459953-DC59187F-7B9C-4909-B824-52A7C83A784FQ37551123-E337DA1C-2550-4967-B4E7-89B64F032202Q37734321-D64E5ACA-D64A-4C09-9660-F5E5CE9D5F29Q38184587-F71F6C59-D7F3-4A29-9CDF-B7E939C16D4BQ39319956-22EF3262-95FA-4709-85C4-EAAA58DAA86CQ41472430-65B3B1C0-3CE1-4516-B648-F5D9DC3E96D4Q49464137-7A5DC668-DEE3-42F7-9C4A-54E048E05EBFQ50175494-1520B5D9-6296-4D29-B3CB-2F9B2957B40E
P2860
Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Genetic variation in soluble e ...... mic stroke in white Europeans.
@en
Genetic variation in soluble epoxide hydrolase
@nl
type
label
Genetic variation in soluble e ...... mic stroke in white Europeans.
@en
Genetic variation in soluble epoxide hydrolase
@nl
prefLabel
Genetic variation in soluble e ...... mic stroke in white Europeans.
@en
Genetic variation in soluble epoxide hydrolase
@nl
P2093
P50
P1433
P1476
Genetic variation in soluble e ...... mic stroke in white Europeans.
@en
P2093
H-Erich Wichmann
Stephan Ripke
Tobias Freilinger
P304
P356
10.1161/STROKEAHA.107.502179
P407
P577
2008-03-06T00:00:00Z